Skip to main content
MedPathMedPath Home
Clinical Trials/ITMCTR2000003812
ITMCTR2000003812
Not yet recruiting
Phase 1

A randomized double-blind controlled clinical study of Qiangxin compound in the treatment of type 2 cardiorenal syndrome under the hierarchical management mode of Integrated Chinese and Western Medicine

Traditional Chinese Medicine Hospital of Shanghai0 sitesTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Traditional Chinese Medicine Hospital of Shanghai
Status
Not yet recruiting
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Sponsor
Traditional Chinese Medicine Hospital of Shanghai

Eligibility Criteria

Inclusion Criteria

  • •Heart failure stage C, D, heart function II to III with mild to severe renal insufficiency.

Exclusion Criteria

  • •1\. Patients with renal insufficiency caused by non cardiac causes;
  • •2\. Pregnant or lactating women, allergic constitution and allergic to a variety of drugs;
  • •3\. Combined with severe liver insufficiency and endocrine system, hematopoietic system and other serious primary diseases;
  • •4\. Those with mental disorder and unwilling to cooperate;
  • •5\. The factors that can increase the mortality rate include cardiogenic shock, severe ventricular arrhythmia, complete atrioventricular block and obvious infection;
  • •6\. Creatinine clearance rate \< 15% of patients requiring dialysis;
  • •7\. History of cardiac surgery.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 4
A randomized double-blind controlled clinical study on the effects of qishen yiqi dropping pills on exercise endurance and quality of life in patients with coronary heart disease after interventional therapy
ITMCTR2100004678China-Japan Friendship Hospital
Completed
Not Applicable
evaluation of the ability of a drug (Tranexamic acid) in reducing blood loss during and after surgery in head and neck cancer patients
CTRI/2018/05/014184AIIMS86
Not yet recruiting
Phase 2
A Clinical trial to study the effect of SDLSNT21 tablet in Patients of Nidranash(Insomnia).Health Condition 1: G470- Insomnia
CTRI/2023/02/049355Dean Faculty of Ayurved
Recruiting
Not Applicable
The Comparison between two method of minisurgical percutaneous dilated tracheostomyThe relationship between two methods of small throat surgery through the skin.
IRCT20150107020592N8Masih Daneshvari Hospital66
Recruiting
Phase 1
Randomized double-blind control clinical study of lower-risk myelodysplastic syndrom (kideny Yang Deficiency) of compound Shenlu granule
ITMCTR2000004040Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine